Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
PetMed Express Inc(PETS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PETS
09/23/2026: PETS (1-star) is currently NOT-A-BUY. Pass it for now.
PetMed Express Inc is an established online pharmacy provider catering to pet owners by offering prescription and non-prescription health products. The company is known for its long-standing brand and specialized focus, though it currently faces significant competitive pressure from large e-commerce platforms that offer broader convenience. Its primary growth opportunity lies in successfully integrating telehealth and wellness services to improve customer engagement and loyalty. The company must navigate intense pricing competition, the risk of customer attrition, and the execution challenges of its digital business transformation. It may suit investors looking for exposure to the pet healthcare niche, provided they monitor management’s ability to stabilize revenue and return to growth.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | The company is currently facing revenue contraction rather than rapid growth. |
| Momentum investor | Weak fit | The stock has lacked sustained positive price momentum in recent years. |
| Value investor | Mixed fit | The stock may appear inexpensive on some metrics, but the underlying business decline presents significant value traps. |
| Dividend investor | Mixed fit | Dividend yields may be attractive but are dependent on the company's ability to maintain cash flow. |
| Low-risk investor | Weak fit | The high competition and business model transition create significant volatility and uncertainty. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is susceptible to large price swings based on earnings performance and competitive news. |
| Valuation risk | Medium | Valuation is sensitive to future growth assumptions which are currently uncertain. |
| Competition risk (E-commerce giants) | High | Market share is constantly threatened by large players with superior scale and shipping capabilities. |
| Business quality | Medium | The company's core pharmacy model faces commoditization and margin pressure. |
| Dividend income | Medium | Dividend payments are not guaranteed and rely on positive earnings. |
| Execution risk | High | Successfully pivoting to a telehealth-integrated model is operationally difficult. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -12.42% | Avg. Invested days 39 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 33.60M USD | Price to earnings Ratio - | 1Y Target Price 2.15 |
Price to earnings Ratio - | 1Y Target Price 2.15 | ||
Volume (30-day avg) 120.6K shares | Beta 0.79 | 52 Weeks Range 1.55 - 4.10 | Updated Date 09/23/2026 |
52 Weeks Range 1.55 - 4.10 | Updated Date 09/23/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.37 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Pharmacy Fulfillment | Sale of prescription and non-prescription pet medications. | This is the primary source of revenue, focused on recurring medication sales. |
| Telehealth and Wellness | Virtual consultations and health advice services. | A growth-oriented segment meant to drive higher customer engagement and retention. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 16.69 | Enterprise Value 21.38M | Price to Sales(TTM) 0.2 |
Enterprise Value 21.38M | Price to Sales(TTM) 0.2 | ||
Enterprise Value to Revenue 0.13 | Enterprise Value to EBITDA 0.63 | Shares Outstanding 21.68M | Shares Floating 13.54M |
Shares Outstanding 21.68M | Shares Floating 13.54M | ||
Percent Insiders 16.63 | Percent Institutions 37.66 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About PetMed Express Inc
Exchange NASDAQ | Headquarters Delray Beach, FL, United States | ||
IPO Launch date 1999-04-26 | Executive Chairman of the Board, Interim CEO & President Ms. Leslie C. G. Campbell | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 189 | Website https://www.1800petmeds.com |
Full time employees 189 | Website https://www.1800petmeds.com | ||
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.